gentaur

Price of adaptation-allostatic load and its health consequences.

BACKGROUND
Exponential development within the inhabitants of older adults presents clinicians with particular issues about elements affecting dangers for declines in cognitive and bodily functioning.
OBJECTIVE
To look at the speculation that dangers for such declines and for illness outcomes, reminiscent of heart problems, are associated to variations in allostatic load, the cumulative physiologic toll exacted on the physique over time by efforts to adapt to life experiences. To current an operational definition of allostatic load, together with preliminary proof of its predictive validity in relation to salient outcomes of growing older.
METHODS
Information from a longitudinal, community-based examine of profitable growing older had been used to develop a measure of allostatic load based mostly on 10 parameters reflecting ranges of physiologic exercise throughout a spread of necessary regulatory techniques. Allostatic load is the sum of the variety of parameters for which the topic was rated within the highest-risk quartile.
RESULTS
Larger allostatic load scores had been related to poorer cognitive and bodily functioning and predicted bigger decrements in cognitive and bodily functioning in addition to being related to an elevated danger for the incidence of heart problems, impartial of sociodemographic and well being standing danger elements.
CONCLUSIONS
Findings are per the conceptualization of allostatic load as an index of wear and tear and tear on the physique, with elevations in allostatic load predicting an elevated danger for a decline in cognitive and bodily functioning in addition to heart problems in a cohort of older women and men. From a scientific perspective, the idea of allostatic load might present the idea for a extra complete evaluation of main dangers within the growing older course of.
gentaur

Human Galectin-1

MBS691972-005mg 0.05mg
EUR 450

Human Galectin-1

MBS691972-5x005mg 5x0.05mg
EUR 1725

Galectin-1, Human

E34M148H 5 μg
EUR 155

Galectin-1 Human

GWB-DAB7E1 0.05 mg Ask for price

Galectin-1, Human

MBS8575305-0005mg 0.005mg
EUR 245

Galectin-1, Human

MBS8575305-5x0005mg 5x0.005mg
EUR 940

Mouse anti Human Galectin-1 Antibody, Mouse MAb

MBS2543309-006mL 0.06mL
EUR 250

Mouse anti Human Galectin-1 Antibody, Mouse MAb

MBS2543309-012mL 0.12mL
EUR 370

Mouse anti Human Galectin-1 Antibody, Mouse MAb

MBS2543309-02mL 0.2mL
EUR 550

Human Galectin-1 (Gal-1) Antibody

30005-05111 150 ug
EUR 215

Human Galectin( Galectin) Elisa Kit

EK711568 96 Wells
EUR 0.18

RABBIT ANTI HUMAN GALECTIN-3:Biotin

MBS222930-005mg 0.05mg
EUR 655

RABBIT ANTI HUMAN GALECTIN-3:Biotin

MBS222930-5x005mg 5x0.05mg
EUR 2780

Rabbit Anti-Human Galectin-1

102-PA131 100ug
EUR 240

Anti-Human Galectin-1 Antibody

102-P131 100 µg
EUR 245.7
Description: Galectin-1, also known as L14, BHL and galaptin, is a monomeric or homodimeric prototype galectin that is expressed in a variety of cells and tissues including muscle, heart, liver, prostate, lymph nodes, spleen, thymus, placenta, testis, retina, macrophages, B cells, T cells, dendritic cells, and tumor cells. It preferentially binds laminin, fibronectin, 90K/Mac2BP, CD45, CD43, CD7, CD2, CD3, and ganglioside GM1. Galectin-1 modulates cell growth and proliferation, either positively or negatively, depending on the cell type and activation status. It controls cell survival by inducing apoptosis of activated T cells and immature thymocytes. It modulates cytokine secretion by inducing Th2 type cytokines and inhibiting proinflammatory cytokine production. Galectin1 can also modulate cel-lcell as well as cell-lmatrix interactions and depending on the cell type and developmental stage, promote cell attachment or detachment. Galectin-1 has immunosuppressive and anti-inflammatory properties and has been shown to suppress acute and chronic inflammation and autoimmunity. Human and mouse galectin1 share about 88% amino acid sequence similarity.

Anti-Human Galectin-1 Antibody

102-PA131AG 50 µg
EUR 157.5
Description: Galectin-1, also known as L14, BHL and galaptin, is a monomeric or homodimeric prototype galectin that is expressed in a variety of cells and tissues including muscle, heart, liver, prostate, lymph nodes, spleen, thymus, placenta, testis, retina, macrophages, B cells, T cells, dendritic cells, and tumor cells. It preferentially binds laminin, fibronectin, 90K/Mac2BP, CD45, CD43, CD7, CD2, CD3, and ganglioside GM1. Galectin-1 modulates cell growth and proliferation, either positively or negatively, depending on the cell type and activation status. It controls cell survival by inducing apoptosis of activated T cells and immature thymocytes. It modulates cytokine secretion by inducing Th2 type cytokines and inhibiting proinflammatory cytokine production. Galectin1 can also modulate cel-lcell as well as cell-lmatrix interactions and depending on the cell type and developmental stage, promote cell attachment or detachment. Galectin-1 has immunosuppressive and antiinflammatory properties and has been shown to suppress acute and chronic inflammation and autoimmunity. Human and mouse galectin1 share about 88% amino acid sequence similarity.

Anti-Human Galectin-1 Antibody

102-PA131S 100 µg
EUR 126
Description: Galectin-1, also known as L14, BHL and galaptin, is a monomeric or homodimeric prototype galectin that is expressed in a variety of cells and tissues including muscle, heart, liver, prostate, lymph nodes, spleen, thymus, placenta, testis, retina, macrophages, B cells, T cells, dendritic cells, and tumor cells. It preferentially binds laminin, fibronectin, 90K/Mac2BP, CD45, CD43, CD7, CD2, CD3, and ganglioside GM1. Galectin-1 modulates cell growth and proliferation, either positively or negatively, depending on the cell type and activation status. It controls cell survival by inducing apoptosis of activated T cells and immature thymocytes. It modulates cytokine secretion by inducing Th2 type cytokines and inhibiting proinflammatory cytokine production. Galectin1 can also modulate cel-lcell as well as cell-lmatrix interactions and depending on the cell type and developmental stage, promote cell attachment or detachment. Galectin-1 has immunosuppressive and antiinflammatory properties and has been shown to suppress acute and chronic inflammation and autoimmunity. Human and mouse galectin1 share about 88% amino acid sequence similarity.

Human Galectin-1 (LGALS1)

1-CSB-EP012882HU
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Galectin-1(LGALS1) expressed in E.coli

Human Galectin-1 (LGALS1)

1-CSB-EP012882HUb1
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • Ask for price
  • 100ug
  • 10ug
  • 1MG
  • 200ug
  • 500ug
  • 50ug
Description: Recombinant Human Galectin-1(LGALS1) expressed in E.coli

human anti-human galectin-3 mAb(2D)

E4A09H10-2D 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human anti-human galectin-3 mAb(5F)

E4A09H10-5F 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human anti-human galectin-3 mAb(A5)

E4A09H10-A5 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human anti-human galectin-3 mAb(G2)

E4A09H10-G2 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human anti-human galectin-3 mAb(H3)

E4A09H10-H3 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

human anti-human galectin-3 mAb(T1)

E4A09H10-T1 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Human Galectin-1 Protein

PRP1033-100g 100 µg
EUR 309

Human Galectin-1 Protein

PRP1033-1mg 1 mg
EUR 1099

Human Galectin-1 Protein

PRP1033-20g 20 µg
EUR 79

Mouse anti Human Galectin-1/LGALS1 Monoclonal Antibody

MBS2543310-006mL 0.06mL
EUR 250

Mouse anti Human Galectin-1/LGALS1 Monoclonal Antibody

MBS2543310-012mL 0.12mL
EUR 370

Mouse anti Human Galectin-1/LGALS1 Monoclonal Antibody

MBS2543310-02mL 0.2mL
EUR 550

human anti-human galectin-3 mAb(N13)

E4A09H10-N13 50ug
EUR 275
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

Rabbit anti Human Galectin-1/LGALS1  Monoclonal Antibody

MBS2543912-006mL 0.06mL
EUR 250

Rabbit anti Human Galectin-1/LGALS1  Monoclonal Antibody

MBS2543912-012mL 0.12mL
EUR 370

Rabbit anti Human Galectin-1/LGALS1  Monoclonal Antibody

MBS2543912-02mL 0.2mL
EUR 550

Rabbit anti Human Galectin-1/LGALS1  Monoclonal Antibody

MBS2543913-006mL 0.06mL
EUR 250

Rabbit anti Human Galectin-1/LGALS1  Monoclonal Antibody

MBS2543913-012mL 0.12mL
EUR 370

Rabbit anti Human Galectin-1/LGALS1  Monoclonal Antibody

MBS2543913-02mL 0.2mL
EUR 550

Anti Human Galectin-3 Polyclonal Antibody

KH040 each
EUR 778.8
Description: The Anti Human Galectin-3 Polyclonal Antibody is available in Europe and for worldwide shipping via Gentaur.

Human Galectin-3(Galectin-3)ELISA Kit

YLA0216HU-48T 48T Ask for price

Human Galectin-3(Galectin-3)ELISA Kit

YLA0216HU-96T 96T Ask for price

Recombinant Human Galectin-1

7-00427 10µg Ask for price

Recombinant Human Galectin-1

7-00428 50µg Ask for price

Recombinant Human Galectin-1

7-00429 1mg Ask for price

Recombinant Human Galectin-1

AP60482 100ug
EUR 449

Recombinant Human Galectin-1

HEOPP-0710 10ug Ask for price

RECOMBINANT HUMAN GALECTIN-1

GWB-BEA2B0 0.05 mg Ask for price

Recombinant Human Galectin-1

cyt-544-10g 10µg
EUR 60

Recombinant Human Galectin-1

cyt-544-1mg 1mg
EUR 1350

Recombinant Human Galectin-1

cyt-544-50g 50µg
EUR 145

Recombinant Human Galectin-1

MBS143303-001mg 0.01mg
EUR 240

Recombinant Human Galectin-1

MBS143303-005mg 0.05mg
EUR 310

Recombinant Human Galectin-1

MBS143303-1mg 1mg
EUR 1515

Recombinant Human Galectin-1

MBS143303-5x1mg 5x1mg
EUR 6485

RECOMBINANT HUMAN GALECTIN-1

MBS232407-005mg 0.05mg
EUR 500

RECOMBINANT HUMAN GALECTIN-1

MBS232407-5x005mg 5x0.05mg
EUR 2070

Recombinant Human Galectin-1

P1229-.01 10ug
EUR 108.8
Description: Peptides & Proteins|Recombinant Proteins

Recombinant Human Galectin-1

P1229-.1 10X10ug
EUR 450.4
Description: Peptides & Proteins|Recombinant Proteins

Recombinant Human Galectin-1

P1229-.5 50X10ug
EUR 1010.4
Description: Peptides & Proteins|Recombinant Proteins

Recombinant Human Galectin-1

MBS9420409-002mg 0.02mg
EUR 285

Recombinant Human Galectin-1

MBS9420409-01mg 0.1mg
EUR 470

Recombinant Human Galectin-1

MBS9420409-1mg 1mg
EUR 1785

Sleep and the worth of plasticity: from synaptic and mobile homeostasis to reminiscence consolidation and integration.

  • Sleep is common, tightly regulated, and its loss impairs cognition. However why does the mind must disconnect from the atmosphere for hours every single day? The synaptic homeostasis speculation (SHY) proposes that sleep is the worth the mind pays for plasticity.

 

  • Throughout a waking episode, studying statistical regularities about the present atmosphere requires strengthening connections all through the mind. This will increase mobile wants for power and provides, decreases signal-to-noise ratios, and saturates studying.

 

  • Throughout sleep, spontaneous exercise renormalizes internet synaptic energy and restores mobile homeostasis. Exercise-dependent down-selection of synapses can even clarify the advantages of sleep on reminiscence acquisition, consolidation, and integration.

 

  • This occurs by the offline, complete sampling of statistical regularities included in neuronal circuits over a lifetime. This Perspective considers the rationale and proof for SHY and factors to open points associated to sleep and plasticity.

 

BACKGROUND
WHO and Well being Motion Worldwide (HAI) have developed a standardised technique for surveying drugs costs, availability, affordability, and worth elements in low-income and middle-income nations. Right here, we current a secondary evaluation of medication availability in 45 nationwide and subnational surveys performed utilizing the WHO/HAI methodology.

Influenza A (A / Brisbane / 10 / 07) H3N2 Protein

abx060621-100g 100 µg Ask for price

Influenza A (A / Brisbane / 10 / 07) H3N2 Protein

abx060621-10g 10 µg
EUR 2250

Influenza A (A / Brisbane / 10 / 07) H3N2 Protein

abx060621-50g 50 µg Ask for price

Influenza A virus H3N2 (Brisbane) Antigen

VAC-0271 0.5ml
EUR 1598.4
Description: Protein

Influenza A Virus H3N2 Brisbane 10/07

7-07948 10µg Ask for price

Influenza A Virus H3N2 Brisbane 10/07

7-07949 50µg Ask for price

Influenza A Virus H3N2 Brisbane 10/07

7-07950 1mg Ask for price

Influenza A Virus H3N2 Brisbane 10/07

MBS143232-001mg 0.01mg
EUR 240

Influenza A Virus H3N2 Brisbane 10/07

MBS143232-005mg 0.05mg
EUR 310

Influenza A Virus H3N2 Brisbane 10/07

MBS143232-1mg 1mg
EUR 2375

Influenza A Virus H3N2 Brisbane 10/07

MBS143232-5x1mg 5x1mg
EUR 10370

H3N2 Influenza-A Virus Brisbane 10/07

rAP-5410 Inquiry Ask for price

H1N1 Influenza A- Virus Brisbane 59/2007 Recombinant

rAP-5423 Inquiry Ask for price

H3N2 Influenza A- Virus Brisbane 10/2007 Recombinant

rAP-5428 Inquiry Ask for price

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (AP)

MBS6481610-01mL 0.1mL
EUR 1090

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (AP)

MBS6481610-5x01mL 5x0.1mL
EUR 4765

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (PE)

MBS6481620-01mL 0.1mL
EUR 1090

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (PE)

MBS6481620-5x01mL 5x0.1mL
EUR 4765

Influenza A H1N1 (A/Brisbane/59/2007) HA protein, His Tag

E40VAG011 20ug
EUR 495

Influenza A H3N2 (A/Brisbane/10/2007) HA protein, His Tag

E40VAG023 20ug
EUR 495

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (APC)

MBS6481611-01mL 0.1mL
EUR 1090

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (APC)

MBS6481611-5x01mL 5x0.1mL
EUR 4765

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (HRP)

MBS6481614-01mL 0.1mL
EUR 1090

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (HRP)

MBS6481614-5x01mL 5x0.1mL
EUR 4765

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (FITC)

MBS6481613-01mL 0.1mL
EUR 1090

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (FITC)

MBS6481613-5x01mL 5x0.1mL
EUR 4765

Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen

11-567 0.1 mg
EUR 632.4
Description: Influenza A (A/Brisbane/10/07), Influenza A Virus, Strain A/Brisbane/10/07 (H3N2)

Influenza A Strain A/Brisbane/10/07 (H3N2) Protein

GWB-T00035 1mg Ask for price

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (Biotin)

MBS6481612-01mL 0.1mL
EUR 1090

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (Biotin)

MBS6481612-5x01mL 5x0.1mL
EUR 4765

Influenza A Virus H3N2 Brisbane 10 / 07 Protein

20-abx260509
  • Ask for price
  • Ask for price
  • Ask for price
  • 10 ug
  • 1 mg
  • 50 ug

Influenza A Virus H3N2 Brisbane 10 / 07 Protein

abx260509-10g 10 µg
EUR 325

Influenza A Virus H3N2 Brisbane 10 / 07 Protein

abx260509-2g 2 µg
EUR 225

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide

11-563 0.05 mg
EUR 632.4
Description: Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide

11-564 0.05 mg
EUR 632.4
Description: Influenza A Hemagglutinin H1 (A/Brisbane/59/2007)(H1N1) Peptide

Influenza B- Virus Brisbane 60/2008 Recombinant

rAP-5434 Inquiry Ask for price

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 405)

MBS6481615-01mL 0.1mL
EUR 1090

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 405)

MBS6481615-5x01mL 5x0.1mL
EUR 4765

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 490)

MBS6481616-01mL 0.1mL
EUR 1090

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 490)

MBS6481616-5x01mL 5x0.1mL
EUR 4765

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 550)

MBS6481617-01mL 0.1mL
EUR 1090

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 550)

MBS6481617-5x01mL 5x0.1mL
EUR 4765

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 650)

MBS6481618-01mL 0.1mL
EUR 1090

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 650)

MBS6481618-5x01mL 5x0.1mL
EUR 4765

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 750)

MBS6481619-01mL 0.1mL
EUR 1090

Influenza A Hemagglutinin H1 (A/Brisbane/59/2007) (H1N1) (MaxLight 750)

MBS6481619-5x01mL 5x0.1mL
EUR 4765

Influenza B (B/Brisbane/60/2008) HA protein, His Tag

E40VAG161 20ug
EUR 495

Influenza B (B/Brisbane/60/2008) HA protein, His Tag

E40VAG163 20ug
EUR 495

Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen Liquid

IFLUABN1007H3N2ALR100UG each
EUR 738
Description: Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen Liquid

Influenza A Strain A/Brisbane/10/07 (H3N2) Antigen Liquid

MBS8431003-INQUIRE INQUIRE Ask for price

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin Antibody Pair Set

ABPR-ZB267 5 plates, 15 plates Ask for price
Description: Quantitative determination of Influenza Hemagglutinin

Influenza A H1N1 (A/Brisbane/59/2007) HA Protein (HA1 Subunit), His Tag

E40VAG010 20ug
EUR 495

Influenza A H3N2 (A/Brisbane/10/2007) HA Protein (HA1 Subunit), His Tag

E40VAG022 20ug
EUR 495

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA ELISA Pair Set

MBS8118343-15Plates 15Plates
EUR 800

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA ELISA Pair Set

MBS8118343-5Plates 5Plates
EUR 450

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA ELISA Pair Set

MBS8118343-5x15Plates 5x15Plates
EUR 3695

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Mouse MAb

MBS8104742-002mL 0.02mL
EUR 185

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Mouse MAb

MBS8104742-01mL 0.1mL
EUR 365

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Mouse MAb

MBS8104742-5x01mL 5x0.1mL
EUR 1490

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb

MBS8104746-002mL 0.02mL
EUR 185

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb

MBS8104746-01mL 0.1mL
EUR 385

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb

MBS8104746-5x01mL 5x0.1mL
EUR 1590

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb

MBS8104747-002mL 0.02mL
EUR 185

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb

MBS8104747-01mL 0.1mL
EUR 385

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb

MBS8104747-5x01mL 5x0.1mL
EUR 1590

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb

MBS8104748-002mL 0.02mL
EUR 185

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb

MBS8104748-01mL 0.1mL
EUR 385

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody, Rabbit MAb

MBS8104748-5x01mL 5x0.1mL
EUR 1590

Recombinant Influenza A virus A/Brisbane/02/2018 (H1N1) Hemagglutinin Antigen

VAC-0017 0.5ml
EUR 2398.4
Description: Protein

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody (HRP), Mouse MAb

MBS8104743-01mg 0.1mg
EUR 440

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody (HRP), Mouse MAb

MBS8104743-5x01mg 5x0.1mg
EUR 1820

Influenza B (B/Brisbane/60/2008) HA Protein (HA1 Subunit), His Tag

E40VAG162 20ug
EUR 495

Influenza B (B/Brisbane/3/2007) HA Protein (HA1 Subunit), His Tag

E40VAG283 20ug
EUR 495

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody (Biotin), Rabbit MAb

MBS8124089-01mg 0.1mg
EUR 470

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Antibody (Biotin), Rabbit MAb

MBS8124089-5x01mg 5x0.1mg
EUR 1955

Rabbit Anti-IBV (Influenza B/Brisbane/60/2008) HA2 Polyclonal Antibody

CABT-CS796 100 μg
EUR 520
Description: Rabbit

Influenza B hemagglutinin (aa1-585) (B/Brisbane/60/2008) cDNA clone

MBS433511-1Each 1Each
EUR 420

Influenza B hemagglutinin (aa1-585) (B/Brisbane/60/2008) cDNA clone

MBS433511-5x1Each 5x1Each
EUR 1740

Influenza A H1N1 (A/Brisbane/02/2018) Neuraminidase/NA Insect Cell Lysate (WB positive control)

MBS8119887-INQUIRE INQUIRE Ask for price

Influenza A H1N1 (A/Brisbane/02/2018) Nucleoprotein/NP Insect Cell Lysate (WB positive control)

MBS8119889-INQUIRE INQUIRE Ask for price

Influenza A H1N1 (A/Brisbane/59/2007) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control)

MBS8114342-03mg 0.3mg
EUR 280

Influenza A H1N1 (A/Brisbane/59/2007) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control)

MBS8114342-5x03mg 5x0.3mg
EUR 1205

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Insect Cell Lysate (WB positive control)

MBS8114355-03mg 0.3mg
EUR 280

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA Insect Cell Lysate (WB positive control)

MBS8114355-5x03mg 5x0.3mg
EUR 1205

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control)

MBS8114357-03mg 0.3mg
EUR 280

Influenza A H3N2 (A/Brisbane/10/2007) Hemagglutinin/HA HEK293 Cell Lysate (WB positive control)

MBS8114357-5x03mg 5x0.3mg
EUR 1205

Recombinant Influenza B virus B/Brisbane/60/2008 Hemagglutinin antigen

VAC-0113 0.5ml
EUR 2398.4
Description: Protein

Influenza A H1N1pdm (Brisbane/2/18) Culture Fluid (Heat Inactivated) (1 mL)

0810585CFHI 1 mL
EUR 422

Recombinant Influenza A virus A/Brisbane/59/2007 (H1N1) Hemagglutinin Antigen (formaldehyde inactivated)

VAC-0023 0.5ml
EUR 2398.4
Description: Protein

Recombinant Influenza A virus A/Brisbane/59/2007 (H1N1) Hemagglutinin Antigen (formaldehyde inactivated)

VAC-0024 0.5ml
EUR 2398.4
Description: Protein

Recombinant Influenza A virus A/Brisbane/59/2007(H1N1) Hemagglutinin Antigen (propiolactone inactivated)

VAC-0025 0.5ml
EUR 2398.4
Description: Protein

Recombinant Influenza A virus A/Brisbane/59/2007(H1N1) Hemagglutinin Antigen (propiolactone inactivated)

VAC-0026 0.5ml
EUR 2398.4
Description: Protein
METHODS
Information from 45 WHO/HAI surveys in 36 nations had been adjusted for inflation or deflation and buying energy parity. Worldwide reference costs from open worldwide procurements for generic merchandise had been used as comparators. Outcomes are offered for 15 medicines included in a minimum of 80% of surveys and 4 particular person medicines.
RESULTS
Common public sector availability of generic medicines ranged from 29.4% to 54.4% throughout WHO areas. Median authorities procurement costs for 15 generic medicines had been 1.11 occasions corresponding worldwide reference costs, though buying effectivity ranged from 0.09 to five.37 occasions worldwide reference costs. Low procurement costs didn’t all the time translate into low affected person costs. Non-public sector sufferers paid 9-25 occasions worldwide reference costs for lowest-priced generic merchandise and over 20 occasions worldwide reference costs for originator merchandise throughout WHO areas. Remedies for acute and power sickness had been largely unaffordable in lots of nations. Within the personal sector, wholesale mark-ups ranged from 2% to 380%, whereas retail mark-ups ranged from 10% to 552%. In nations the place worth added tax was utilized to medicines, the quantity charged diverse from 4% to 15%.
CONCLUSIONS
Total, private and non-private sector costs for originator and generic medicines had been considerably increased than can be anticipated if buying and distribution had been environment friendly and mark-ups had been cheap. Coverage choices reminiscent of selling generic medicines and various financing mechanisms are wanted to extend availability, cut back costs, and enhance affordability.
Gina

Leave a Comment

Your email address will not be published.